OneSource Specialty Pharma Limited (BOM:544292)
India flag India · Delayed Price · Currency is INR
1,573.50
-17.75 (-1.12%)
At close: Oct 28, 2026

BOM:544292 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23
Net Income
-16.21-738.03-179.71-3,912-7,998
Depreciation & Amortization
2,8402,7482,696941.84656.8
Other Amortization
42.5842.5842.411.96-
Loss (Gain) From Sale of Assets
24.12.042.25-539.5-
Asset Writedown & Restructuring Costs
----7.11
Loss (Gain) From Sale of Investments
-4.51-3.27---
Stock-Based Compensation
5.8127.143.1319.5659.59
Provision & Write-off of Bad Debts
203.2125.56.9--
Other Operating Activities
1,058646.69915.812,7028,788
Change in Accounts Receivable
-3,865-1,896-2,571-514.17198.21
Change in Inventory
-1,205-2,809439.93-4.03-579.03
Change in Accounts Payable
2,5982,089-1,176-160.94150.97
Change in Other Net Operating Assets
-1,389-149.73-891.13637.84446.85
Operating Cash Flow
292.285.23-678.54-1,072-1,628
Operating Cash Flow Growth
75.19%----

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23
Capital Expenditures
-4,116-5,691-1,281-637.67-439.95
Sale of Property, Plant & Equipment
7.740.10.923.97-
Divestitures
----37.91-
Investment in Securities
-23.61-128.4243.15,532-
Other Investing Activities
411.11869.17-773.35245.36-238.39
Investing Cash Flow
-3,721-4,950-2,0115,105-678.34

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23
Short-Term Debt Issued
-1,399950.53-1,034
Long-Term Debt Issued
-5,6392,5006,452528.52
Total Debt Issued
8,1977,0383,4516,4521,562
Short-Term Debt Repaid
----1,303-926.05
Long-Term Debt Repaid
--2,310-6,520-8,021-4,048
Lease Payments
-247.34-236.06-209.85-65.63-85.1
Total Debt Repaid
-4,276-2,310-6,520-9,325-4,974
Net Debt Issued (Repaid)
3,9214,728-3,070-2,873-3,411
Issuance of Common Stock
31.5157.458,755-5,648
Other Financing Activities
-1,416-1,191-1,565-1,033-1,053
Financing Cash Flow
2,5373,5944,120-3,9051,183

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23
Miscellaneous Cash Flow Adjustments
--0.22--
Net Cash Flow
-892-1,2701,431127.9-1,123

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23
Free Cash Flow
-3,824-5,605-1,960-1,710-2,068
Free Cash Flow Growth
-----
Free Cash Flow Margin
-22.73%-39.38%-13.56%-99.45%-534.07%
Free Cash Flow Per Share
-33.35-48.94-17.75-41.15-51.93
Levered Free Cash Flow
-5,092-6,951-3,344-705.22-
Unlevered Free Cash Flow
-4,371-6,255-2,381-171.48-
Free Cash Flow After Leases
-4,071-5,842-2,170-1,775-2,153

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23
Cash Interest Paid
1,1911,1911,5651,0331,053
Cash Income Tax Paid
878770.12--109.31
Change in Working Capital
-3,860-2,766-4,199-41.3217